Kinetics of hallmark biochemical changes in paclitaxel-induced apoptosis

J L Au1, R R Kumar, D Li

  • 1College of Pharmacy, The Ohio State University, 500 West 12th Aveneue, Columbus, OH 43210, USA. Au.1@osu.edu

AAPS Pharmsci
|December 14, 2001
PubMed

Insights

Paclitaxel-induced apoptosis in prostate cancer cells involves sequential biochemical events. Caspase activation precedes poly-ADP-ribose polymerase cleavage and DNA fragmentation, with cell detachment indicating later-stage apoptosis.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Cancer Research

Background:

  • Apoptosis involves biochemical cascades like caspase activation, PARP cleavage, and DNA fragmentation.
  • Understanding the kinetics of drug-induced apoptosis is crucial for pharmacodynamic studies.
  • Paclitaxel's delayed effects are linked to slow apoptosis manifestation.

Purpose of the Study:

  • To investigate the temporal sequence of biochemical changes during paclitaxel-induced apoptosis in human prostate PC3 cancer cells.
  • To differentiate apoptotic events in attached versus detached cells.

Main Methods:

  • Human prostate PC3 cancer cells were treated with 20 nM paclitaxel.
  • Cell detachment, caspase activation, PARP cleavage, and DNA fragmentation were monitored over 96 hours.
  • Biochemical markers were analyzed in both attached and detached cell populations.

Main Results:

  • Paclitaxel treatment led to increased cell detachment over time (68% at 96 hours).
  • Detached cells showed full apoptotic changes; attached cells exhibited only partial caspase activation.
  • Caspase activation preceded PARP cleavage and DNA fragmentation by 12 hours in detached cells.

Conclusions:

  • Paclitaxel-induced apoptosis involves a distinct temporal order of caspase activation, PARP cleavage, and DNA fragmentation.
  • Cell detachment appears to be associated with later stages or completion of apoptosis.
  • The study provides insights into the kinetics of apoptosis for designing cancer therapy studies.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...